Skip to main content

Advertisement

Log in

Summary

This study evaluated the efficacy of rabdosia rubescens against gingivitis and compared the therapeutic efficacy of different dosage forms of rabdosia rubescens. A multi-center, randomized, double-blind, double-simulation, positive-controlled and parallel trial was conducted. A total of 136 patients exhibiting clinical symptoms of gingivitis were enrolled. The subjects were randomly assigned to two groups: test group (n=67), in which rabdosia rubescens drop pill (960 mg) and 4 tablets of simulation agent of rabdosia rubescen were orally given to the subjects three times a day for 5 days; and control group (n=69), in which the subjects were administered the tablets of rabdosia rubescens (1000 mg) and 24 drop pills of simulation agent of rabdosia rubescens thrice daily for 5 days. The experimental protocols and diagnostic criteria were established by expert panel prior to the experiment. The clinical symptoms were graded according to the severity of the disease and quantified. The total scores and scores for each clinical symptom of gingivitis were assessed at baseline and on the 6th day post-treatment. The therapeutic efficacy was compared between the two groups and in each group itself before and after the treatment. The results showed that in the two groups, the subjects who were given rabdosia rubescens, drop pill or tablet, had a decrease in total scores and scores for each clinical symptom when compared with those before treatment (P<0.01). There was significant difference in the therapeutic efficacy between the test group and the control group with the efficacy rate being 92.54% and 79.71% respectively (P<0.05). It was concluded that rabdosia rubescens showed great promise in treating gingivitis. And rabdosia rubescens drop pill was more efficacious than rabdosia rubescens tablet.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Li Q, Chen Z, Liu J, et al. Effect of oridonin on the hemodynamics in anaesthetized rabbits. Chin Pharm Bull (Chinese), 1993(1):53–55

  2. Li Q, Liu J, Chen Z, et al. Effect of oridonin on the hemodynamics in rabbits and its mechanism research. J Norman Bethune Univ Med Sci (Chinese), 1994,20(2):128–129

    Google Scholar 

  3. Su XH, Dong CM, Wang WL, et al. Dy namics research of main secondary metabolites accumulation in rabdosia rubescens tissue culture. Zhongguo Zhong Yao Za Zhi (Chinese), 2008,33(9):1080–1084.

    Google Scholar 

  4. Feng N, Wu P, Li Q, et al. Oridonin-loaded poly(epsilon-caprolactone)-poly (ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma. J Drug Target, 2008,16(6):479–485

    Article  PubMed  CAS  Google Scholar 

  5. Ikezoe I, Chen SS, Tong XJ, et al. Oridonin induces growth inhibition and apoptosis of a variety of human cancer cell. Int J Oncol, 2003,23(4):1187–1193

    PubMed  CAS  Google Scholar 

  6. Cheng Y, Qiu F, Ye YC, et al. Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells. FEBS J, 2009, 276(5):1291–1306

    Article  PubMed  CAS  Google Scholar 

  7. Li D, Wu LJ, Tashiro S, et al. Oridonin induces human epidermoid carcinoma A431 cell apoptosis through tyrosine kinase and mitochondrial pathway. J Asian Nat Prod Res, 2008,10(1–2):77–87

    Article  PubMed  CAS  Google Scholar 

  8. Wang YF, Jiang JH, Wang QR. et al. Antitumor and immunological activities of polysaccharides from rabdosia rubescens. Chin J Pathophysiol (Chinese), 2002,18(11): 1341–1343

    CAS  Google Scholar 

  9. Liu YQ, You S, Tashiro S, et al. Roles of Ras and extracellular signal-regulated kinase-dependent IkappaBalpha degradation in oridonin-enhanced phagocytosis of apoptotic cells by human macrophage-like U937 cells. Int Immunopharmacol, 2006,6(2):260–268

    Article  PubMed  CAS  Google Scholar 

  10. Liu YQ, You S, Tashiro S, et al. Activation of phosphoinositide 3-kinase, protein kinase C, and extracellular signal-regulated kinase is required for oridonin-enhanced phagocytosis of apoptotic bodies in human macrophage-like U937 cells. J Pharmacol Sci, 2005,98(4): 361–371

    Article  PubMed  CAS  Google Scholar 

  11. Zhang Y, Wang Y. Effect of rebescensine A on removal of active free radicals. Henan Med Res (Chinese), 1998, 8(2):100–104

    Google Scholar 

  12. Xu X, Zhang XL. Study of Oridonin on antioxidation. J Strait Pharm (Chinese), 2002,16(6):28–31

    Google Scholar 

  13. Sagar SM, Yance D, Wonq RK. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr Oncol, 2006,13(1):14–26

    PubMed  CAS  Google Scholar 

  14. Adams LS, Seeram NP, Hardy ML, et al. Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines. Evid Based Complement Alternat Med, 2006,3(1):117–124

    Article  PubMed  Google Scholar 

  15. Zhou GB, Kang H, Wang L, et al. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo. Blood, 2007,109(8):3441–3450

    Article  PubMed  CAS  Google Scholar 

  16. Yu YN, Yu YX. One case-therapy of acute pharyngitis with Rabdosia rubescens. Chin Remed Clin (Chinese), 2002,2(3):l71

    Google Scholar 

  17. Feng ZY, Zhang FL, Tian XJ. Observation for therapeutic effect of compound rabdosia rubescens toroche on cute pharyngitis and cute pharyngitis. J Youjiang Med (Chinese), 2006,34(6):599–601

    Google Scholar 

  18. Cao CF. Periodontics. 2nd ed. Beijing: People’s Medical Publishing House, 2005,75–107

    Google Scholar 

  19. Zhuang ZY. Oral Science. 6th ed. Beijing: People’s Medical Publishing House, 2004,54–72

    Google Scholar 

  20. Li Q, Feng WS. The latest development of researches on the chemical constituents and pharmacological activity of rabdosia rubescens hara. J Henan Univ Chin Med (Chinese), 2003,18(6):31–33

    Google Scholar 

  21. Dai H, Liu SH, Zhou X, et al. Research progress of pharmacological actions and clinical application of rabdosia rubescens. Sichuan J Physiol Sci (Chinese), 2008, 30(1):20–21

    Google Scholar 

  22. Hua HY, Zhu JL, Ye QX. Experimental research on bacteriostatic effect of rabdosia rubescens drop pill and table in vitro and in vivo. Chin Trad Herb Drug (Chinese), 2006,37(Suppl):79–81

    Google Scholar 

  23. Song FJ, Wu SJ, Liang JJ. Study on antibacterial activity about isodon rubescens from badong. J South-Central Univ Natl (Natural Science Edition) (Chinese), 2004, 23(4):9–11

    Google Scholar 

  24. Duan XY, Wang YH. Experimental research on bacteriostatic effect of compound rabdosia rubescens toroche in vitro. J Henan col Trad Chin Med (Chinese), 1997,12(6):38–39

    Google Scholar 

  25. Xu ZK. Rabdosia rubescens expected to be the second taxol. Modern Chin Med (Chinese), 2007,9(8):43–45

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sui Chen  (陈穗).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, S., Liu, J. & Zhang, H. Efficacy of rabdosia rubescens in the treatment of gingivitis. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 29, 659–663 (2009). https://doi.org/10.1007/s11596-009-0525-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-009-0525-2

Key words

Navigation